tube feeding or parenteral nutrition. patients with scores 5 or above per the ordinal scale for clinical improvement published by the who. (i.e., who need oxygen supply beyond use of nozzles or simple mask) need for admission to icu during the present hospitalization at any time prior to completion of the recruitment to the study. any condition which, in the opinion of the principal investigator, would prevent full participation in this trial or would interfere with the evaluation of the trial endpoints.

tube feeding or parenteral nutrition. patients with scores 5 or above per the ordinal scale for clinical improvement published by the who. (i.e., who need oxygen supply beyond use of nozzles or simple mask) need for admission to icu during the present hospitalization at any time prior to completion of the recruitment to the study. any condition which, in the opinion of the principal investigator, would prevent full participation in this trial or would interfere with the evaluation of the trial endpoints.

1. tube feeding or parenteral nutrition. 2. patients with scores 5 or above per the ordinal scale for clinical improvement published by the who. (i.e., who need oxygen supply beyond use of nozzles or simple mask) 3. need for admission to icu during the present hospitalization at any time prior to completion of the recruitment to the study. 4. any condition which, in the opinion of the principal investigator, would prevent full participation in this trial or would interfere with the evaluation of the trial endpoints.

1. tube feeding or parenteral nutrition. 2. patients with scores 5 or above per the ordinal scale for clinical improvement published by the who. (i.e., who need oxygen supply beyond use of nozzles or simple mask) 3. need for admission to icu during the present hospitalization at any time prior to completion of the recruitment to the study. 4. any condition which, in the opinion of the principal investigator, would prevent full participation in this trial or would interfere with the evaluation of the trial endpoints.